Epidemiology of anemia in the elderly: Information on diagnostic evaluation

Journal of the American Geriatrics Society

Volumn 51, Issue 3 SUPPL., 2003, Pages 2-9

  Balducci, Lodovico ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Aging; Anemia of chronic disease; Diagnosis; Epidemiology; Erythropoietin

Indexed keywords

CYANOCOBALAMIN; CYTOKINE; ERYTHROPOIETIN; FOLIC ACID; GROWTH FACTOR; IRON;

AGED; ANEMIA; COGNITION; CONFERENCE PAPER; CYANOCOBALAMIN DEFICIENCY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ELDERLY CARE; EPIDEMIOLOGICAL DATA; ERYTHROPOIESIS; FOLIC ACID DEFICIENCY; GLOMERULUS FILTRATION RATE; HEMATOPOIETIC SYSTEM; HUMAN; INCIDENCE; IRON DEFICIENCY; KIDNEY FAILURE; LIFE EXPECTANCY; MEDICAL INFORMATION; MORTALITY; PATHOPHYSIOLOGY; POPULATION RESEARCH; PREVALENCE;

EID: 0037344160     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.51.3s.4.x     Document Type: Conference Paper

References (55)

1. United States Bureau of the Census. Population projections of the United States by age, sex, race, and Hispanic origin: 1995-2050. Current Population Reports 1998:1125-1130.
2. Anía BJ, Suman VJ, Fairbanks VF et al. Incidence of anemia in older people: An epidemiologic study in a well defined population. J Am Geriatr Soc 1997; 45:825-831.
3. Gabrilove J. Overview: Erythropoiesis, anemia, and the impact of erythropoietin. Semin Hematol 2000;37(Suppl. 6):1-3.
4. Spivak JL, Barnes DC, Fuchs E et al. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 1989;261:3104-3107.
5. Cleeland CS, Demetri GD, Glaspy J et al. Identifying hemoglobin levels for optimal quality of life: Results of an incremental analysis. Proc Am Soc Clin Oncol 1999;18:574a.
6. Gabrilove JL, Cleeland CS, Livingstone RB et al. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 2001;19:2875-2882.
7. Littlewood TJ, Bajetta E, Nortier JW et al. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001;19:2865-2874.
8. Kulier A, Gombozt H. Perioperative anemia. Anaesthetist 2001;50:73-86.
9. Carson JL, Poses RM, Spence RK et al. Severity of anemia and operative mortality and morbidity. Lancet 1988;1:727-729.
10. Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 1993;21:860-866.
11. Chaves P, Ashar T, Guralnik JM et al. Looking at the relationship between hemoglobin concentration and previous mobility difficulty in older women. Should the criteria used to define anemia in older people be changed? J Am Geriatr Soc 2002;50:1257-1264.
12. Chaves PH, Volpato S, Fried L. Challenging the World Health Organization criteria for anemia in older women. J Am Geriatr Soc 2001;3:10.
13. Glaspy J, Bukowski R, Steinberg C et al. Impact of therapy with epoetin alfa on clinical outcomes in patients with non-myeloid malignancies during cancer chemotherapy in community oncology practices. J Clin Oncol 1997;5: 1218-1234.
14. Demetri GD, Kris M, Wade J et al. Quality of life: benefits in chemotherapy patients treated with epoetin alfa is independent from disease response and tumor type. Result of a prospective community oncology study. The Procrit Study Group. J Clin Oncol 1998;16:3412-3420.
15. Smith DL. Anemia in the elderly. Am Fam Physician 2000;62:1565-1572.
16. Anía BJ, Suman VJ, Fairbanks VF et al. Prevalence of anemia in medical practice: Community versus referral patients. Mayo Clin Proc 1994;69:730-735.
17. Inelmen EM, Alessio MD, Gatto MRA et al. Descriptive analysis of the prevalence of anemia in a randomly selected sample of elderly people at home: Some results of an Italian multicentric study. Aging Clin Exp Res 1994;6:81-89.
18. Mansouri A, Lipschitz DA. Anemia in the elderly patient. Anemia 1992;76: 619-630.
19. Quaglino D, Ginaldi L, Furia N et al. The effect of age on hemostasis. Aging Clin Exp Res 1996;8:11-12.
20. Tran KH, Udden MM, Taffet GE et al. Erythropoietin regulation of hematopoiesis is preserved in healthy elderly people. Clin Res 1993;41:16a.
21. Zauber PN, Zauber AG. Hematologic data of healthy very old people. JAMA 1987;257:2181-2184.
22. Balducci L, Hardy CL, Lyman GH. Hematopoietic growth factors in the older cancer patient. Curr Opin Hematol 2001;8:170-187.
23. Cohen HJ, Piper CS, Harris T. Markers of inflammation and coagulation predict decline in function and mortality in community dwelling elderly. J Am Geriatr Soc 2001;S1:A3.
24. Hamerman D, Berman JW, Albers GW et al. Emerging evidence for inflammation in conditions frequently affecting older adults. Report of a symposium. J Am Geriatr Soc 1999;47:995-999.
25. Joosten E, Pelemans W, Hiele M et al. Prevalence and causes of anaemia in a geriatric hospitalised population. Gerontology 1992;38:111-117.
26. Anderson S, Brenner BM. Effects of aging on the renal glomerulus. Am J Med 1986;80:435-442.
27. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999;130: 461-470.
28. Chiari MM, De Bagnoli R, Luca P et al. Influence of acute inflammation on iron and nutritional status indexes in older inpatients. J Am Geriatr Soc 1995;43:767-771.
29. Murphy PT, Hutchinson RM. Identification and treatment of anaemia in older patients. Drugs Aging 1994;4:113-127.
30. Abramson SD, Abramson N. 'Common' uncommon anemias. Am Fam Physician 1999;59:851-858.
31. Walsh JR. Hematologic problems. In: Hazzard W, ed. Geriatric Medicine. New York: Springer, 1997, pp. 627-636.
32. Kranz SB. Pathogenesis and treatment of the anemia of chronic disease. Am J Med Sci 1994;307:353-359.
33. Daly MP. Anemia in the elderly. Am Fam Physician 1989;39:129-136.
34. Wians FH Jr, Urban JE, Keffer JH et al. Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status vs transferrin receptor concentration. Am J Clin Pathol 2001;115:112-118.
35. Gabrilove JL, Einhorn LH, Livingston RB et al. Once weekly dosing of epoetin alfa is similar to three-times weekly dosing in increasing hemoglobin and quality of life. Proc Am Soc Clin Oncol 1999;18:574a.
36. Nafziger J, Pailla K, Luciani L et al. Decreased erythropoietin responsiveness to iron deficiency anemia in the elderly. Am J Hematol 1993;43:172-176.
37. Kario K, Matsuo T, Kodoma K et al. Reduced erythropoietin secretion in senile anemia. Am J Hematol 1992;41:252-257.
38. Carpenter MA, Kendall RG, O'Brian AE et al. Reduced erythropoietin response to anaemia in elderly patients with normocytic anaemia. Eur J Haematol 1992;49:119-121.
39. Duthie E. Physiology of aging: Relevance to symptom perceptions and treatment tolerance. In: Balducci L, Lyman GH, Ershler WB, eds. Comprehensive Geriatric Oncology. London: Harwood Academic Publishers, 1998, pp. 247-262.
40. Pickett JL, Theberge DC, Brown WS et al. Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis 1999;33:1122-1130.
41. Metivier F, Marchais SJ, Guerin AP et al. Pathophysiology of anaemia: Focus on the heart and blood vessels. Nephrol Dial Transplant 2000;15(Suppl. 3):14-18.
42. Tong EM, Nissenson AR. Eryrhropoietin and anemia. Semin Nephrol 2001; 21:190-203.
43. NIH Healthy People. Healthy People 2010. Chronic Kidney Disease 2000. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 2000.
44. Besarab A, Flaharty KK, Erslev AJ et al. Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease: The case for subcutaneous administration. J Am Soc Nephrol 1992;2:1405-1416.
45. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996;156:1097-1100.
46. 12 deficiency after gastric surgery. Ann Intern Med 1996;124:469-476.
47. 12) deficiency using the urinary methylmalonic acid assay by gas chromatography mass spectrometry. Am J Med 1993;94:589-594.
48. Kuzminski AM, Del Giacco EJ, Allen RH et al. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998;92:1191-1198.
49. 12 due to gastric or intestinal dysfunction. Semin Nucl Med 1972;2:220-234.
50. 12 deficiency on older veterans and its relationship to health. J Am Geriatr Soc 1998;46:1199-1206.
51. Goodnough LT, Price TH, Parvin CA. The endogenous erythropoietin response and the erythropoietic response to blood loss anemia: The effects of age and gender. J Lab Clin Med 1995;126:57-64.
52. Powers JS, Kantz SB, Collins JC et al. Erythropoietin response to anemia as a function of age. J Am Geriatr Soc 1991;39:30-32.
53. Fried LP, Storer DJ, King DE et al. Diagnosis of illness presentation in the elderly. J Am Geriatr Soc 1991;39:117-123.
54. Ahluwalia N, Lammi-Keefe CJ, Bendel RB et al. Iron deficiency and anemia of chronic disease in elderly women: A discriminate-analysis approach for differentiation. Am J Clin Nutr 1995;61:590-596.
55. Hassaballa H. Anemia in older patients. JAMA 1999;282:2001.